This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global live cell imaging market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study include publications from government sources, such as American Society for Cell Biology (ASCB), Cancer Research UK (CRUK), International Society for Stem Cell Research (ISSCR), European Molecular Biology Organization (EMBO), Clinical and Contract Research Association (CCRA), Association of International Contract Research Organizations (AICROS), Clinical and Contract Research Association (CCRA), American Association of Pharmaceutical Scientists (AAPS), Eurostat, Food and Drug Administration (FDA), Pharmaceutical Research and Manufacturers of America (PhRMA), PubMed, Government Associations. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global live cell imaging market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global live cell imaging market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the live cell imaging market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
-
The key players in the industry and market have been identified through extensive primary and secondary research.
-
The revenues generated from the live cell imaging business of leading players have been determined through primary and secondary research.
-
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Market Definition
Live cell imaging involves the detailed study of living cells using images acquired from microscopes and high-content screening systems. This technique is mainly used in scientific research activities for a better understanding of biological functions through the study of cellular dynamics.
Stakeholders
-
Manufacturers of live cell imaging equipment and consumables
-
Suppliers and distributors of live cell imaging technologies
-
Research institutes and academic centers
-
Pharmaceutical & biotechnology companies
-
Contract research organizations (CROs)
-
Business research and consulting service providers
-
Venture capitalists
-
Regulatory bodies
-
Government bodies/municipal corporations
Report Objectives
-
To define, describe, and forecast the global live cell imaging market based on product & service, application, technology, end user, and region
-
To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
-
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
-
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
-
To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
-
To track and analyze competitive developments such as acquisitions, product/ service launches, expansions, agreements, partnerships, and collaborations in the market
HIGHEST CAGR MARKET IN 2022
CHINA FASTEST GROWING MARKET IN THE REGION
Growth opportunities and latent adjacency in Live Cell Imaging Market